Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas. (Q55466955)

12 July 2018

title

Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas. (English)

1 reference

12 July 2018

author name string

Fabio M Iwamoto

1

1 reference

12 July 2018

Linda Nicolardi

2

1 reference

12 July 2018

Alexis Demopoulos

3

1 reference

12 July 2018

Violetta Barbashina

4

1 reference

12 July 2018

Paulo Salazar

5

1 reference

12 July 2018

Marc Rosenblum

6

1 reference

12 July 2018

Adília Hormigo

7

1 reference

12 July 2018

publication date

15 March 2008

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

88

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

293-298

1 reference

12 July 2018

Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-008-9563-Z

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

21 January 2018

1 reference

12 December 2020

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

1 reference

12 December 2020

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

12 December 2020

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss

1 reference

12 December 2020

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

1 reference

12 December 2020

Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.

1 reference

12 December 2020

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas

1 reference

12 December 2020

Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors

1 reference

12 December 2020

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

12 December 2020

Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy

1 reference

12 December 2020

Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene

1 reference

12 December 2020

Molecular pathology and clinical characteristics of oligodendroglial neoplasms

1 reference

12 December 2020

Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas

1 reference

12 December 2020

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

12 December 2020

Two types of chromosome 1p losses with opposite significance in gliomas

1 reference

12 December 2020

Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas.

1 reference

12 December 2020

10.1007/S11060-008-9563-Z

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

1021988626

0 references

1 reference

12 July 2018